These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 33604704)
1. Translating genetic association of lipid levels for biological and clinical application. Crone B; Krause AM; Hornsby WE; Willer CJ; Surakka I Cardiovasc Drugs Ther; 2021 Jun; 35(3):617-626. PubMed ID: 33604704 [TBL] [Abstract][Full Text] [Related]
2. Recent developments in genome and exome-wide analyses of plasma lipids. Lange LA; Willer CJ; Rich SS Curr Opin Lipidol; 2015 Apr; 26(2):96-102. PubMed ID: 25692345 [TBL] [Abstract][Full Text] [Related]
3. Coding-sequence variants are associated with blood lipid levels in 14,473 Chinese. Lu X; Li J; Li H; Chen Y; Wang L; He M; Wang Y; Sun L; Hu Y; Huang J; Wang F; Liu X; Chen S; Yu K; Yang X; Mo Z; Lin X; Wu T; Gu D Hum Mol Genet; 2016 Sep; 25(18):4107-4116. PubMed ID: 27516387 [TBL] [Abstract][Full Text] [Related]
13. Analysis of exome-sequenced UK Biobank subjects implicates genes affecting risk of hyperlipidaemia. Curtis D Mol Genet Metab; 2020; 131(1-2):277-283. PubMed ID: 32747172 [TBL] [Abstract][Full Text] [Related]
14. From lipid locus to drug target through human genomics. van der Laan SW; Harshfield EL; Hemerich D; Stacey D; Wood AM; Asselbergs FW Cardiovasc Res; 2018 Jul; 114(9):1258-1270. PubMed ID: 29800275 [TBL] [Abstract][Full Text] [Related]
15. The genetic spectrum of familial hypercholesterolemia in the central south region of China. Xiang R; Fan LL; Lin MJ; Li JJ; Shi XY; Jin JY; Liu YX; Chen YQ; Xia K; Zhao SP Atherosclerosis; 2017 Mar; 258():84-88. PubMed ID: 28235710 [TBL] [Abstract][Full Text] [Related]
16. The Contribution of GWAS Loci in Familial Dyslipidemias. Ripatti P; Rämö JT; Söderlund S; Surakka I; Matikainen N; Pirinen M; Pajukanta P; Sarin AP; Service SK; Laurila PP; Ehnholm C; Salomaa V; Wilson RK; Palotie A; Freimer NB; Taskinen MR; Ripatti S PLoS Genet; 2016 May; 12(5):e1006078. PubMed ID: 27227539 [TBL] [Abstract][Full Text] [Related]
17. Identification of a novel LDLR disease-causing variant using capture-based next-generation sequencing screening of familial hypercholesterolemia patients in Taiwan. Hsiung YC; Lin PC; Chen CS; Tung YC; Yang WS; Chen PL; Su TC Atherosclerosis; 2018 Oct; 277():440-447. PubMed ID: 30270083 [TBL] [Abstract][Full Text] [Related]
18. Association of Monogenic vs Polygenic Hypercholesterolemia With Risk of Atherosclerotic Cardiovascular Disease. Trinder M; Francis GA; Brunham LR JAMA Cardiol; 2020 Apr; 5(4):390-399. PubMed ID: 32049305 [TBL] [Abstract][Full Text] [Related]
19. Using genetic variants to evaluate the causal effect of cholesterol lowering on head and neck cancer risk: A Mendelian randomization study. Gormley M; Yarmolinsky J; Dudding T; Burrows K; Martin RM; Thomas S; Tyrrell J; Brennan P; Pring M; Boccia S; Olshan AF; Diergaarde B; Hung RJ; Liu G; Legge D; Tajara EH; Severino P; Lacko M; Ness AR; Davey Smith G; Vincent EE; Richmond RC PLoS Genet; 2021 Apr; 17(4):e1009525. PubMed ID: 33886544 [TBL] [Abstract][Full Text] [Related]
20. Meta-GWAS on PCSK9 concentrations reveals associations of novel loci outside the PCSK9 locus in White populations. Kheirkhah A; Schachtl-Riess JF; Lamina C; Di Maio S; Koller A; Schönherr S; Coassin S; Forer L; Sekula P; Gieger C; Peters A; Köttgen A; Eckardt KU; Kronenberg F Atherosclerosis; 2023 Dec; 386():117384. PubMed ID: 37989062 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]